Acadia is trailblazing breakthroughs in neuroscience to elevate life through science. Our caring and courageous family aspires to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. Our late-stage development efforts are focused on central nervous system disorders and Ret syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, and cognition and neuropsychiatri symptoms in central nervous system disorders. Visit our Booth No. #101. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn.
Acadia
North Central LTC National Account Manager
12830 El Camino Real, Suite 400
San Diego, CA 92130
Deborah Wasano RN BSN PHN
Email: dwasano@acadia-pharm.com
Cell: 210-380-1148
Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with
great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders.
Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego, CA 92130
Michelle Griffin
Key Account Manager
Email: mgriffin@neurocrine.com
At our core is perseverance, a fierce determination to overcome any obstacle regardless of setbacks, on behalf of patients and their loved ones. We place greater value on what we can achieve together than on what we can do alone because the needs of those we serve always come first. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear: Otsuka-people, creating new products for better health worldwide.
Our Focus
We are doing everything in our power to live up to our mission in three important categories.
Neuroscience
Our driving philosophy at Otsuka is to serve those with unmet medical needs, and that couldn’t be more true than in our dedication to the central nervous system (CNS) space. In our 30 years of experience working in this therapeutic area, we continue to innovate and defy limitation by taking risks to overcome the complexities of treating mental health. We respect the value within every mind and are committed to making a difference in the lives of patients living with schizophrenia, major depressive disorder, bipolar disorder, and other CNS conditions.
Nephrology
When Otsuka saw a need for clinical expertise and research in the nephrology space, we decided to lead the way. For more than 20 years, we have been bringing our research and expertise to this therapeutic area. We have focused on developing novel drugs in areas of unmet need, such as autosomal dominant polycystic kidney disease and hyponatremia, that have changed the treatment landscape. Our long-term perseverance has led to major breakthroughs, giving patients renewed hope and clinicians more options than ever before.
Digital Innovation
Digital technology has not only changed the world we live in, but it is also changing the face of healthcare. Otsuka is at the forefront of this transformative juncture in medicine, creating novel solutions that help address the challenges of those living with serious mental illness. We believe our investment and leadership in this therapeutic area will revolutionize patient care as we know it. Patients will be able to engage and communicate with their care teams in new ways, and clinicians will have data-driven insights that may help inform treatment decisions.
OAPI and OPDC Locations
508 Carnegie Center Dr,
Princeton, NJ 08540, United States
2440 Research Blvd,
Rockville, MD 20850, United States
3956 Point Eden Way
Hayward, CA 94545, United States
30 Enterprise, Suite 200
Aliso Viejo, CA 92656, United States
We are Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.
Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.
We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
Sanofi/Vaccines
Susan Manganello, RN, BSN
Lead, Public Affairs and Patient Advocacy
Vaccines
Email: susan.manganello@sanofi.com
Phone: 570-202-2034
Sunovion Pharmaceuticals Inc
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. With patients at the center of everything it does, Sunovion has an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. Visit us at www.sunovion.com.
Sunovion
207 Redlands Street
Playa Del Rey, CA 90293
Pamela Eubanks
Email: pamela.eubanks@sunovion.com
Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing and commercializing therapies for patients. Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma Co., Ltd., intends to develop treatments for additional diseases. Learn more about us at www.urovant.com.
Urovant Sciences, Inc.
5281 California Avenue, Suite 100
Irvine, CA 92617
Joe Ndukwe
Director, KOL Marketing
Email: joe.ndukwe@urovant.com
Mobile: +1 949-241-1276
VIATRIS™
VIATRIS™ is a new kind of healthcare company, committed to providing access to medicines, advancing sustainable operations, developing innovative solutions and improving patient outcomes. Formed in 2020 through the combination of Mylan and Upjohn, Viatris brings together best-in-class scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities.
Viatris
1000 Mylan Blvd.
Canonsburg, PA 15317
Joseph Roylance (4 copies)
Regional Account Manager Respiratory
Email: joseph.roylance@viatris.com
Mobile: 801.678.5265